Myeloma | Tumor

Novel Injectable Drug Shows Promise in Relapsed/Refractory Myeloma

June 11th 2021, 1:00pm


Treatment with an investigational drug induced high response rates in patients with relapsed or refractory multiple myeloma.

Single-Injection CAR-T Cell Therapy Improves Long-Term Treatment Responses in Relapsed/Refractory Multiple Myeloma

June 8th 2021, 9:00pm


Patients with relapsed/refractory myeloma who were previously treated with three or more therapies responded to an infusion of a novel CAR-T cell therapy up to 18 months with no new side effects compared with 12-month results of this study.

Kyprolis-Based Regimen Induces Similar Results as Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

June 8th 2021, 6:30pm


The study’s lead author noted that a survival outcome, along with other results, was similar among the two groups.

Abecma Continues to Improve Survival in Heavily Pretreated Patients With Multiple Myeloma

June 6th 2021, 8:00pm


After long-term follow-up, the CAR-T cell therapy still boosted survival outcomes in patients with relapsed/refractory multiple myeloma, regardless of the number of prior lines of therapy received.

Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma

June 5th 2021, 8:00pm


A single infusion of a novel CAR-T cell therapy was associated with early and deep responses to treatment among a certain group of patients with multiple myeloma.

Taking Control of Multiple Myeloma

June 2nd 2021, 4:09pm


Donna and Dr Gasparetto close the discussion by highlighting the importance of physicians utilizing their patients, as well as patients being involved with their multiple myeloma treatment.

Donna’s Advice to Multiple Myeloma Patients

June 2nd 2021, 4:03pm


Donna gives advice to other multiple myeloma patients about what she has learned from living with this disease and her various therapies.

New Personalized Treatment Method Developed to Improve Outcomes in Older Multiple Myeloma Patients

May 26th 2021, 1:00pm


Researchers have developed Myeloma Drug Sensitivity Testing to determine which medications will be most effective with minimal side-effects.

Carfilzomib for Multiple Myeloma and Donna’s Second Relapse

May 21st 2021, 1:45pm


Cristina Gasparetto, MD, discusses Donna’s relationship with the drug carfilzomib for multiple myeloma therapy, as well as her second relapse.

Multiple Myeloma First- and Second-Line Therapies for Donna

May 21st 2021, 1:45pm


Donna and Dr Gasparetto converse about the many first- and second-line therapies for multiple myeloma.